AI Can Make a Difference for Healthcare, but It Needs Support

The American healthcare system desperately needs support. The American population is aging, and life expectancy is increasing, with those 65 or older accounting for one out of every five Americans by 2030—and 80 percent of those having at least one chronic condition. Healthcare costs are increasing; costs have already risen [...]

By |2024-03-20T14:22:27-04:00March 20th, 2024|Artificial Intelligence/AI, Blog, CHI, Connect health, Policy|

Empowering Innovation: A Unified Call for Action on National Standards and Fair SEP Licensing Policies

To address the existing power imbalances and transparency issues within the standard-essential patent (SEP) licensing landscape, members of ACT | The App Association recently sent a letter to members of the House and Senate Judiciary Committees. This letter underscores the App Association’s support for the Administration’s National Standards Strategy for [...]

By |2024-03-06T16:38:46-05:00March 6th, 2024|App Economy, Blog, FRAND, Innovation and IP, Policy, Tech Regulation, Trends|

AI Regulation in focus: balancing innovation and governance in the EU and UK

With global governments in a race to regulate, policymakers in the European Union (EU) and United Kingdom (UK) are considering various approaches to rules around artificial intelligence (AI). Last year, we outlined a flexible, thoughtful approach to AI policy and governance that considers the latest data privacy security laws as [...]

Make the EU ex-SEP-tional: Be a friend to SME innovation and vote yes on the EU SEP Regulation

  Recently, the Legal Affairs Committee of the European Parliament took a significant step forward in advancing the much-needed standard-essential patent (SEP) regulation in the European Union that would curb SEP licensing practices that continue to harm and distort competition across consumer and enterprise markets. This development is important to [...]

By |2024-02-06T18:27:13-05:00February 6th, 2024|App Economy, Blog, Innovation and IP, Patents, Policy, Tech Regulation|
Go to Top